NICE approves Voxelotor, the first sickle cell treatment, for use on the NHS in England.
The UK's National Institute for Health and Care Excellence (Nice) has approved Voxelotor, a new treatment for sickle cell disease, for use on the NHS in England. This is the first sickle cell treatment to be recommended by the health watchdog. The drug, taken as a daily tablet, is said to considerably enhance the quality of life for sickle cell patients by lowering their need for blood transfusions, which results in fewer hospital visits.
May 02, 2024
41 Articles